2 Groups model FDA [Two-Stage / GS Designs]

posted by hiren379 – India, 2013-08-22 14:32 (2542 d 03:27 ago) – Posting: # 11336
Views: 34,458


» Followed by:
» If the Group-by-treatment interaction test is not statistically significant (p ≥0.1), only the Group-by-treatment term can be dropped from the model.
» … provided that the group meets minimum requirements for a complete bioequivalence study.

According to the above statement, what should be the minimum requirements of the group for a complete bioequivalence study?

Complete thread:

 Admin contact
20,977 posts in 4,374 threads, 1,460 registered users;
online 19 (0 registered, 19 guests [including 10 identified bots]).
Forum time: Friday 17:59 CEST (Europe/Vienna)

When someone says his conclusions are objective,
he means that they are based on prejudices
which many other people share.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz